Showing results (1191-1200 of 5,224) with videos related to
Sort By:
Pageof 523
Antiviral Research|March 6, 2024
Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin AMaja Klevanski, Heeyoung Kim, Mike Heilemann, et al.Antiviral Research|February 19, 2024
Mechanism of action of phthalazinone derivatives against rabies virusVictoire Perraud, Bart Vanderhoydonck, Guillaume Bouvier, et al.Antiviral Research|February 18, 2024
Neutralizing antibodies to block viral entry and for identification of entry inhibitorsEe Hong Tam, Yu Peng, Megan Xin Yan Cheah, et al.Antiviral Research|February 24, 2024
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patientsYannick Debing, Hannah Vanrusselt, Lars Degrauwe, et al.Antiviral Research|February 2, 2024
Therapeutic antibodies and alternative formats against SARS-CoV-2Rahel R Winiger, Laurent PerezAntiviral Research|February 8, 2024
Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory virusesDivya Sinha, Melyssa Yaugel-Novoa, Louis Waeckel, et al.Antiviral Research|January 27, 2024
Discovery of new antiviral agents through artificial intelligence: In vitro and in vivo resultsRoza Izmailyan, Mher Matevosyan, Hamlet Khachatryan, et al.Antiviral Research|May 11, 2024
New technologies in therapeutic antibody development: The next frontier for treating infectious diseasesSheila M Keating, Brett W HigginsAntiviral Research|April 28, 2024
Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infectionsAdam J Gehring, Loghman SalimzadehAntiviral Research|April 24, 2024
Discovery of baloxavir sodium as a novel anti-CCHFV inhibitor: Biological evaluation of in vitro and in vivoKai Liu, Liushuai Li, Yajie Liu, et al.Pageof 523